Ads
related to: frontotemporal dementia
Search results
Stifel Nicolaus Trims Denali Therapeutics (NASDAQ:DNLI) Target Price to $22.00
ETF DAILY NEWS· 1 day agoDenali Therapeutics (NASDAQ:DNLI – Free Report) had its target price decreased by Stifel Nicolaus from $26.00 to $22.00 in a research report sent to investors on Wednesday, Benzinga reports.
Weekend Picks: Barcelona Flamenco Ballet at Granada; Halloween, Alaska
MinnPost· 4 days agoPlus: MIZU + OHYUNG at The Cedar; Ghoulish Delights brings the suspense; Tara Costello explores...
Coya Therapeutics Reports First Quarter 2024 Financial Results
Guru Focus· 2 days agoOn May 9, 2024, Coya Therapeutics Inc (COYA, Financial), a trailblazer in biologics for enhancing regulatory T cell function, disclosed its financial outcomes for the first quarter ended March ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 3 days agoCompany to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated